This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Streptococcus dysgalactiae Glyceraldehyde-3-Phosphate Dehydrogenase (gapA), N-His
Product Overview
BioVenic's Recombinant Streptococcus dysgalactiae Glyceraldehyde-3-Phosphate Dehydrogenase (gapA), N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 38.0 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from Streptococcus dysgalactiae is a key enzyme in the glycolytic pathway, converting glyceraldehyde-3-phosphate into 1,3-bisphosphoglycerate. In veterinary medicine, GAPDH is significant for its potential role in vaccine development against S. dysgalactiae infections, which are prevalent in animals such as pigs. It can also serve as a target for therapeutic interventions, as it is involved in the bacterium's energy metabolism and survival. Understanding GAPDH's function may lead to strategies that disrupt bacterial processes, offering new avenues for treatment and control of infections in veterinary practice.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.